Cargando…
Preoperative Systemic Inflammatory Biomarkers Are Independent Predictors of Disease Recurrence in ER+ HER2- Early Breast Cancer
The host’s immune system plays a crucial role in determining the clinical outcome of many cancers, including breast cancer. Peripheral blood neutrophils and lymphocytes counts may be surrogate markers of systemic inflammation and potentially reflect survival outcomes. The aim of the present study is...
Autores principales: | Truffi, Marta, Piccotti, Francesca, Albasini, Sara, Tibollo, Valentina, Morasso, Carlo Francesco, Sottotetti, Federico, Corsi, Fabio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8600180/ https://www.ncbi.nlm.nih.gov/pubmed/34804977 http://dx.doi.org/10.3389/fonc.2021.773078 |
Ejemplares similares
-
Prognostic Potential of Immune Inflammatory Biomarkers in Breast Cancer Patients Treated with Neoadjuvant Chemotherapy
por: Truffi, Marta, et al.
Publicado: (2022) -
Fast quantification of extracellular vesicles levels in early breast cancer patients by Single Molecule Detection Array (SiMoA)
por: Morasso, Carlo, et al.
Publicado: (2021) -
Lipofilling in Breast Oncological Surgery: A Safe Opportunity or Risk for Cancer Recurrence?
por: Piccotti, Francesca, et al.
Publicado: (2021) -
Prediction of nodal staging in breast cancer patients with 1-2 sentinel nodes in the Z0011 era
por: Corsi, Fabio, et al.
Publicado: (2020) -
Whitlockite has a characteristic distribution in mammary microcalcifications and it is not associated with breast cancer
por: Morasso, Carlo, et al.
Publicado: (2023)